中国急性缺血性卒中诊治指南2023  

Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023

作　　者：中华医学会神经病学分会 中华医学会神经病学分会脑血管病学组 彭斌[2] 王拥军[3] 姚明[4] Chinese Society of Neurology;Chinese Stroke Society;Peng Bin;Wang Yongjun(不详;Department of Neurology,Peking Union Medical College Hospital,Peking Union Medical College and Chinese Academy of Medical Sciences,Beijing 100730,China;Department of Neurology,Beijing Tiantan Hospital,Capital Medical University,China National Clinical Research Center for Neurological Diseases,Beijing 100070,China)

机构地区：[1]不详 [2]中国医学科学院北京协和医院神经科,北京100730 [3]首都医科大学附属北京天坛医院神经内科,国家神经系统疾病临床医学研究中心,北京100070 [4]中国医学科学院北京协和医院

出　　处：《中华神经科杂志》2024年第6期523-559,共37页Chinese Journal of Neurology

摘　　要：自《中国急性缺血性脑卒中诊治指南2018》发布以来(本版指南中“脑卒中”简称为“卒中”),缺血性卒中诊治领域取得了显著进展。基于此背景,中华医学会神经病学分会、中华医学会神经病学分会脑血管病学组组织专家,结合国内外相关领域进展,对指南进行更新,突出急性期静脉溶栓、血管内机械取栓、抗血小板药物治疗等多方面的进展,以期体现急性缺血性卒中全面诊治管理的最新规范,指导临床医师工作。Since release of the Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018,substantial and significant progresses have been made during the past 5 years.It is necessary to update evidence-based guidelines in the management of acute ischemic stroke,and further improve the standardization of clinical practice.The Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2023 is approved by Chinese Society of Neurology,Chinese Stroke Society.The present guidelines systematically provide an up-to-date recommendations for management of acute ischemic stroke,especially in intravenous thrombolysis,endovascular treatment and antithrombotic therapy.

关 键 词：卒中 诊断 治疗 指南 

分 类 号：R743.3[医药卫生—神经病学与精神病学]